Investor Relations

A leadership story in the field of advanced cell therapy

Day High:
Day Low:
Volume:
on
Copyright West LLC. Minimum 15 minutes delayed.

Investor Relations

Press Releases

October 22, 2020

Vericel to Report Third-Quarter 2020 Financial Results on November 5, 2020

October 14, 2020

Vericel Announces Preliminary Third Quarter 2020 Total Net Revenues of $32 Million

October 9, 2020

Vericel To Host Virtual Analyst and Investor Day on October 16, 2020

Events and Presentations

 

 

Presentations
More information is coming soon.

Stock Quote & Analyst Coverage

Stock Quote ()

Change
Volume
Today's Open
Previous Close
Today's High
Today's Low
52 Week High
52 Week Low
Vericel Corporation is covered by the following analysts.
Ryan Zimmerman
BTIG
Swayampakula Ramakanth
H.C. Wainwright & Co.
Jeff Cohen
Ladenburg Thalmann
Danielle Antalffy
LEERINK
Chad Messer
Needham
Kevin DeGeeter
Oppenheimer
Kaila Krum
Truist

Vericel Corporation is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Vericel Corporation's performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Vericel Corporation or its management. Vericel Corporation does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.